In June of 2011, just two days after Actos was pulled off the shelves in France and Germany, the FDA warned doctors and patients in the U.S. about the increased risk of bladder cancer while taking the medicine for over a year. Takeda, the largest pharmaceutical company based in Japan, is now facing hundreds of…
Continue reading ›and Compassion

